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Abstract. 
 
The generation of cortical actin ﬁlaments is 
necessary for processes such as cell motility and cell po-
larization. Several recent studies have demonstrated 
that Wiskott-Aldrich syndrome protein (WASP) family 
proteins and the actin-related protein (Arp) 2/3 com-
plex are key factors in the nucleation of actin ﬁlaments 
in diverse eukaryotic organisms. To identify other fac-
tors involved in this process, we have isolated proteins 
that bind to Bee1p/Las17p, the yeast WASP-like pro-
tein, by afﬁnity chromatography and mass spectro-
scopic analysis. The yeast type I myosins, Myo3p and 
Myo5p, have both been identiﬁed as Bee1p-interacting 
proteins. Like Bee1p, these myosins are essential for 
cortical actin assembly as assayed by in vitro reconstitu-
tion of actin nucleation sites in permeabilized yeast 
cells. Analysis using this assay further demonstrated 
that the motor activity of these myosins is required for 
the polymerization step, and that actin polymerization 
depends on phosphorylation of myosin motor domain 
by p21-activated kinases (PAKs), downstream effectors 
of the small guanosine triphosphatase, Cdc42p. The 
type I myosins also interact with the Arp2/3 complex 
through a sequence at the end of the tail domain ho-
mologous to the Arp2/3-activating region of WASP-like 
proteins. Combined deletions of the Arp2/3-interacting 
domains of Bee1p and the type I myosins abolish actin 
nucleation sites at the cortex, suggesting that these pro-
teins function redundantly in the activation of the 
Arp2/3 complex.
Key words: myosin • actin • Cdc42 • actin-related 
protein (Arp) 2/3 complex • Wiskott-Aldrich syndrome 
protein (WASP)
 
Introduction
 
Type I myosins are highly conserved proteins that appear
to play roles in numerous processes, such as endocyto-
sis, membrane trafficking, contractility, and cell motility
(Mooseker and Cheney, 1995). In some eukaryotic organ-
isms, these proteins localize to the leading edge of motile
cells and are speculated to power membrane protrusion
(Fukui et al., 1989; Wagner et al., 1992). The motor activ-
ity of type I myosins in amoebae depends on phosphory-
lation of the motor domain by p21-activated kinases
(PAKs),
 
1
 
 downstream targets of Rho family small GTP-
ases (Maruta and Korn, 1977; Brzeska et al., 1997, 1999).
The same phosphorylation site, known as the TEDS-rule
phosphorylation site, also exists in yeast type I myosins
and type VI myosins of mammalian cells (Wu et al., 1997;
Buss et al., 1998), but the in vivo significance of this phos-
phorylation in Rho family GTPase-regulated cellular pro-
cesses has not been demonstrated.
Budding yeast contains two type I myosins, Myo3p and
Myo5p, which are functionally redundant in vivo (Good-
son et al., 1996). These myosins consist of an NH
 
2
 
-terminal
motor domain with F-actin binding and ATPase activity
and IQ motifs for binding to a light chain. The COOH-ter-
minal tail of the type I myosins includes a putative lipid-
binding domain, a second F-actin binding domain (TH2
domain), an Src homology domain 3 (SH3) domain, and
an acidic tail motif (see Results). Therefore, the tail has
the potential to interact with a variety of proteins and
membrane lipids. Double knockout of 
 
MYO3
 
 and 
 
MYO5
 
results in defects in polarized cell growth and endocytosis,
but it is not known how the myosins participate in these
actin-based processes. In vitro, these myosins are phos-
phorylated at the conserved site by Ste20p and Cla4p, two
yeast PAKs (Wu et al., 1997). Phosphorylation is required
for function in vivo, as a nonphosphorylatable Myo3p mu-
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tant does not rescue the growth defect of the double myo-
sin I–null (Wu et al., 1997). Ste20p and Cla4p are effectors
of the small GTPase Cdc42p (for review see Daniels and
Bokoch, 1999), which is required for polarized cell growth
during bud formation (Adams et al., 1990). Thus, yeast
provides an excellent system for elucidating the in vivo
function and regulation of type I myosins.
Cdc42 is required for cell polarity and actin polymeriza-
tion in a number of systems. A requirement for Cdc42 ac-
tivity in actin assembly has been shown in permeabilized
yeast cells, and 
 
Acanthamoeba
 
, 
 
Dictyostelium
 
, 
 
Xenopus
 
,
and neutrophil extracts (Li et al., 1995; Zigmond et al.,
1997; Ma et al., 1998; Mullins and Pollard, 1999). The
mechanisms by which Cdc42 promotes actin assembly
have been the subject of recent research. In both 
 
Dictyo-
stelium
 
 and 
 
Xenopus
 
 egg extracts, the actin-related protein
(Arp) 2/3 complex is required for Cdc42-induced actin as-
sembly (Ma et al., 1999; Mullins and Pollard, 1999). This
highly conserved seven-polypeptide complex is thought to
catalyze the de novo nucleation of actin filaments, the
rate-limiting step in actin polymerization (Cooper et al.,
1983; Tobacman and Korn, 1983). It is also required for
the actin polymerization-driven motility of pathogenic
bacteria such as 
 
Listeria monocytogenes
 
 and 
 
Shigella flex-
neri 
 
(Welch et al., 1997; Egile et al., 1999). The nucleation
activity of purified Arp2/3 complex is low but can be
greatly stimulated by the 
 
Listeria
 
 ActA protein (Welch
et al., 1998), and by members of the Wiskott-Aldrich syn-
drome protein (WASP) family, including WASP, neuronal
(N)-WASP, WAVE/SCAR1, and Bee1p/Las17p (Ma-
chesky et al., 1999; Rohatgi et al., 1999; Winter et al.,
1999a; Yarar et al., 1999). This activation is dependent
upon a COOH-terminal acidic domain conserved among
all WASP family members (Machesky and Insall, 1998).
Both WASP and N-WASP contain a Cdc42-binding motif
(Aspenstrom et al., 1996; Miki et al., 1996; Symons et al.,
1996). It has been shown that the ability of N-WASP to ac-
tivate the nucleation activity of the Arp2/3 complex is de-
pendent upon binding to Cdc42p (Rohatgi et al., 1999). It
is believed that Cdc42 binding induces a conformational
change in N-WASP, exposing its Arp2/3 activation do-
main. WAVE and Bee1p lack the Cdc42-interacting do-
main, and how they link signal transduction pathways to
actin assembly is not yet known.
Our study started from an attempt to define functional
components of cortical actin assembly sites using an in
vitro reconstitution assay (Lechler and Li, 1997). In this
assay, a Cdc42-dependent actin nucleation activity associ-
ated with cortical patches in permeabilized yeast cells was
first eliminated by treatment with 2 M urea and reconsti-
tuted by incubation with a cytoplasmic extract. The extract
was then washed away and actin polymerization at cortical
patches was assayed after the addition of rhodamine-
labeled actin monomers (G-actin). This approach led to
the identification of Bee1p, a yeast member of the WASP
family, as one of the proteins required for the first step of
the reconstitution (Lechler and Li, 1997). However, the
lack of a Cdc42-binding motif suggested that signaling to
actin polymerization was occurring in a different manner
in this system. Furthermore, deletion of the acidic Arp2/3-
binding domain of Bee1p has little effect on actin assem-
bly and cell growth, suggesting that Bee1p is unlikely to be
 
the sole activator of the Arp2/3 complex (Winter et al.,
1999a). In this study, we first identified the yeast type I
myosins as Bee1p-interacting proteins that are also re-
quired for cortical actin assembly in the permeabilized
cells. Subsequent analysis provided evidence that these
myosins have multiple roles in cortical actin assembly:
they mediate Cdc42 regulation of actin polymerization
through motor domain phosphorylation; and they function
redundantly with Bee1p in the activation of the Arp2/3
complex.
 
Materials and Methods
 
Plasmid Construction
 
The Myo5
 
D
 
C-hemagglutinin (HA) construct was prepared by PCR of the
promoter (
 
2
 
284) and the first 1169 codons of MYO5 using genomic DNA
and the primers 5
 
9
 
-GCGCGCGCGGCCGCGGTGTGTTTTAACTCG-
TCGG-3
 
9
 
 and 5
 
9
 
-GCGCGCGGATCCTTGTACAGAATTCAGAAC-
GGG-3
 
9
 
. The product was digested with NotI and BamHI and ligated
into PRL129, an HA-tagging vector derived from PRS306. The Myo3
 
D
 
C-
HA construct was generated by PCR using the primers 5
 
9
 
-GCG-
CGCGCGGCCGCCCTCGGGAAGAGCTTTACCG-3
 
9
 
 and 5
 
9
 
-GCGC-
GCGAATTCGTGGGGACGTTTAGCGACGG-3
 
9
 
. The product was
digested with NotI and EcoRI and ligated into PRL129. The glutathione
 
S
 
-transferase (GST)-Myo3A–expressing plasmid was made by PCR of
the acidic domain of MYO3 using the primers 5
 
9
 
-GCGCGCGAA-
TTCGTGGGGACGTTTAGCGACGG-3
 
9
 
 and 5
 
9
 
-GCGCGCGAATT-
CACTCTGATTATCACTAGTGGG-3
 
9
 
, digesting the product with
EcoRI, and ligating into the EcoRI site of pGEX4T-1. The GST-Myo5A
construct was created by subcloning of the Myo5p acidic domain. Full-
length MYO5 was subjected to PCR and ligated into NotI, BamHI sites of
Bluescript. The EcoRI fragment containing the acidic domain was then
cloned into pGEX4T-1. The rigor mutant of Myo3p was created by PCR-
based mutagenesis of p1846 (a Myo3-HA–containing plasmid obtained
from Charlie Boone, Queens University, Kingston, Ontario) using the
primers 5
 
9
 
-GCTTCTGTCTTACCCGCTCTAGACTCACC-3
 
9
 
 and 5
 
9
 
-
GGTGAGTCTAGAGCGGGTAAGACAGAAGC-3
 
9
 
.
 
Strain Construction
 
The 
 
myo5
 
D
 
A 
 
D
 
myo3 
 
D
 
myo5
 
 strain was constructed by transforming a
 
myo5
 
D
 
A
 
-carrying plasmid (a COOH-terminal 50 amino acid [aa] dele-
tion) into the double mutant background. The 
 
bee1
 
D
 
A
 
 strain was created
by deletion of the COOH-terminal 33 codons of the 
 
BEE1
 
 gene by ho-
mologous recombination. Deletion was confirmed by PCR and Western
blot analysis. The 
 
bee1
 
D
 
A myo5
 
D
 
A 
 
D
 
myo3 
 
strain was made by crossing
the 
 
bee1
 
D
 
A
 
 strain with the 
 
myo5
 
D
 
A 
 
D
 
myo3 
 
D
 
myo5
 
 strain and subse-
quently selecting haploids with the desired genotype. All yeast strains
used in this study are listed in Table I.
 
Isolation of Bee1p-Interacting Proteins
 
Extracts were prepared from RLY650 cells by passing cells suspended in
UB (50 mM Hepes, pH 7.5, 100 mM KCl, 3 mM MgCl
 
2
 
, 1 mM EGTA,
1 mM DTT, supplemented with protease inhibitors as described [Li et al.,
1995]) through a French pressure cell at 2,300 psi. A high-speed superna-
tant was obtained by centrifugation at 250,000 
 
g
 
 for 1 h. Ammonium sul-
fate was added to the resulting extract to bring it to 30% saturation (the
protein A–tagged Bee1 is efficiently precipitated at this concentration).
Precipitated protein was collected by centrifugation, resuspended in UB,
and clarified. IgG–Sepharose beads (Amersham Pharmacia Biotech) were
added to this solution and subsequently washed with UB
 
 
 
plus
 
 
 
0.5%
Tween 20, and then UB
 
 
 
plus
 
 
 
1 M KCl. Protein was then eluted with 0.5 M
acetic acid, pH 3.6. Bee1p-associated proteins were separated by one-
dimensional SDS-PAGE and identified by high mass accuracy matrix-
assisted laser desorption/ionization (MALDI) peptide mapping as de-
scribed (Shevchenko et al., 1996a). In brief, protein bands visualized by
staining with Coomassie were excised from the gel. Proteins were reduced
by dithiothreitol, alkylated with iodoacetamide, and in-gel digested with
trypsin (unmodified, sequencing grade; Boehringer Mannheim) at 37
 
8
 
C
overnight (Shevchenko et al., 1996b). 0.5-
 
m
 
l aliquots of the supernatant 
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were withdrawn from the digests and analyzed on a REFLEX MALDI
TOF mass spectrometer (Bruker Daltonics). Mass spectra were internally
calibrated using known m/z of ions originating from the matrix and autol-
ysis products of trypsin. Database searches were performed using Pep-
tideSearch 3.0 software developed in European Molecular Biology Labo-
ratory. No limitations on protein molecular weights and species of origin
were imposed. 18 (38) peptides were matched to the sequence of Myo3p
(Myo5p) with the mass accuracy better than 75 ppm. These peptides cov-
ered 17 and 39% of the sequence of Myo3p and Myo5p, respectively.
 
Protein Purification and Interaction Assays
 
GST-Myo3A contained the COOH-terminal 38 aa of Myo3p, and GST-
Myo5A and GST-Bee1A contained the COOH-terminal 54 aa of each
protein. Extracts were prepared from bacteria that were induced to ex-
press these proteins. Fusion proteins were purified on glutathione-aga-
rose, washed extensively with PBS plus
 
 
 
0.5% Tween 20, eluted with re-
duced glutathione, and then equilibrated into UB. Arp2/3 complex was
purified as described (Winter et al., 1999a). Purified Arp2/3 complex at 50
nM was incubated with fusion protein coupled beads, washed with UB
plus
 
 
 
0.4% Tween 20, and then eluted into SDS-PAGE sample buffer. Im-
munoprecipitations were performed from 20 mg/ml, 250,000 
 
g
 
 yeast ex-
tracts prepared by the liquid nitrogen grinding technique. In brief, anti-
HA (monoclonal 12CA5 ascites; BABCO) or anti-myc (Evan et al., 1985)
coupled protein A beads were incubated with extract at 4
 
8
 
C for 1 h. After
washing extensively with UB
 
 
 
plus
 
 
 
0.4% Tween 20, proteins were eluted
into SDS-PAGE sample buffer. For immunodepletions, concentrated ex-
tracts were treated as for immunoprecipitations, but the supernatant was
removed for analysis.
 
Actin Assembly Assays
 
Small-budded cells and rhodamine-labeled actin were prepared as de-
scribed (Li et al., 1995). The actin assembly and reconstitution assays in
permeabilized cells was performed as described (Li et al., 1995; Lechler
and Li, 1997). In brief, frozen small budded cells were permeabilized by
incubation in 0.5 mg/ml saponin for 30 min, treated with 2 M urea for 25
min to inactivate actin assembly activity, and then incubated with con-
centrated extracts for 25 min. Extract was washed away and rhodamine-
labeled actin was added to the permeabilized cells in polymerization
buffer (UB plus
 
 
 
1 mM ATP). After an 8-min incubation, cells were fixed
with formaldehyde and observed by fluorescence microscopy. All incuba-
tions were at 27
 
8
 
C. For 
 
cdc42-1
 
–containing strains, the cells were grown at
34
 
8
 
C for 2 h before freezing. For pharmacologic experiments, 2,3-butane-
dione 2-monoxime (BDM) (gift of T.J. Mitchison, Harvard Medical
School, Boston, MA) was used at 20 mM, and adenosine 5
 
9
 
-[beta, gamma-
imido]triphosphate (AMPPNP) (Sigma Chemical Co.) at 1 mM. Inhibi-
tors were added either with concentrated extracts during the reconstitu-
tion, or with labeled actin during the polymerization. For the dephos-
phorylation experiments, concentrated extracts were treated with 10 U
alkaline phosphatase (Boehringer Mannheim) for 20 min at 37
 
8
 
C before
incubation with cells.
 
Fluorescent Microscopy
 
Rhodamine-phalloidin (Molecular Probes) staining was performed as de-
scribed (Pringle et al., 1989). Rhodamine-labeled actin (Kellogg et al.,
1988) and phalloidin were imaged with a Zeiss Axiophot microscope with
a HB100 W/Z high pressure mercury lamp and a Zeiss 100
 
3
 
 Plan Neo-
fluar oil immersion objective. Image acquisition was carried out using
Northern Exposure (Phase 3 Imaging Systems).
 
Results
 
Bee1p Interacts with Type I Myosins
 
We demonstrated previously that Bee1p is required for ac-
tin assembly activity in permeabilized yeast cells. In part,
Bee1p may function through activation of the Arp2/3 com-
plex’s nucleation activity. However, Bee1p contains sev-
eral putative protein–protein interaction motifs, and ap-
pears to function with other proteins in the reconstitution
of actin assembly (Lechler and Li, 1997). Therefore, an
affinity chromatography strategy was used to identify
Bee1p-interacting proteins. Bee1p was tagged at its COOH
terminus with four repeats of the IgG binding domain of
protein A (Bee1-PrA). Under the endogenous 
 
BEE1
 
 pro-
moter, this construct rescued the growth defect of the
 
D
 
bee1
 
 mutation (data not shown). Extracts were prepared
from this strain, precipitated with ammonium sulfate to
enrich for Bee1p, and then subjected to affinity chroma-
tography on IgG–Sepharose beads. The ammonium sul-
fate treatment concentrates Bee1p, and possibly its bind-
ing partners as well, from the extract by 
 
z
 
28-fold. Bound
proteins were eluted with acid, separated by SDS-PAGE,
and individual protein bands were identified by mass spec-
troscopy. Two proteins that bound specifically to Bee1-
PrA and were present in approximately stoichiometric
amounts were identified as Myo3p and Myo5p, the two
type I myosins of budding yeast (Fig. 1 A). Characteriza-
tion of other proteins will be published elsewhere. Re-
ciprocal immunoprecipitation was carried out to verify
the Bee1–myosin interaction in a strain that expresses
HA-tagged Myo3p at an endogenous level. Although
Bee1p was not detected in a control immunoprecipitate,
the anti-HA immunoprecipitate specifically and reproduc-
ibly brought down Bee1p (Fig. 1 B). However, only a small
 
Table I. Yeast Strains
 
Name Genotype Source
 
RLY1 MATa 
 
his3-
 
D
 
200 leu2-3 lys2-801 ura3-52
 
Drubin lab
RLY171 MATa 
 
leu2-3 ura3-52 cdc42-1
 
Drubin lab
RLY446 MATa 
 
ade2 his3-
 
D
 
200 leu2-3 trp1-1 ura3-52 bar1 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pMYO3-HA 
 
(p1846) This work
RLY454 MATa 
 
his3-
 
D
 
200 leu2-3 lys2-801 ura3-52 trp1-1 
 
D
 
vrp1::TRP1 pMYO3-HA
 
 (p1846) This work
RLY650 MATa 
 
his3-
 
D
 
200 leu2-3 lys2-801 ura3-52 
 
D
 
bee1::LEU2 pBEE1-PrA
 
 (pTL84) Winter et al., 1999
RLY802 MATa 
 
ade2 can1 his3-
 
D
 
200 leu2-3 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pmyo3-S357A
 
 (pVL97) This work
RLY803 MATa 
 
ade2 can1 his3-
 
D
 
200 leu2-3 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pMYO3-S357D
 
 (pVL98) This work
RLY804 MATa 
 
ade2 can1 his3-
 
D
 
200 leu2-3 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pMyo5
 
D
 
C-HA
 
 (pTL88) This work
RLY805 MATa 
 
ade2 can1 his3-
 
D
 
200 leu2-3 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pMyo3
 
D
 
C-HA
 
 (pTL91) This work
RLY817 MATa 
 
his3-
 
D
 
200 3 lys2-801 trp1-1 ura3-52 
 
D
 
myo3::HIS3
 
This work
RLY819 MATa 
 
his3-
 
D
 
200 leu2-3 lys2-801 trp1-1 ura3-52 
 
D
 
myo5::TRP1
 
This work
RLY822 MATa 
 
his3-
 
D
 
200 lys2-801 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1
 
This work
RLY865 MATa 
 
his3-
 
D
 
200 leu2-3 lys2-801 trp1-1 ura3-52 
 
D
 
myo3::HIS3 
 
D
 
myo5::TRP1 pmyo3-G132R-HA
 
 (pTL103) This work
RLY871 MATa his3-D200 leu2-3 lys2-801 trp1-1 ura3-52 Dmyo3::HIS3 Dmyo5::TRP1 URA3::myo5DC bee1DC::LEU2 This work
RLY889 MATa leu2-3 ura3-52 cdc42-1 pmyo3-S357A (pVL97) This work
RLY890 MATa leu2-3 ura3-52 cdc42-1 pMYO3-S357D (pVL98) This workThe Journal of Cell Biology, Volume 148, 2000 366
fraction (,1%) of the total Bee1p was immunoprecipi-
tated under these conditions, suggesting that the interac-
tion is of low affinity. Concentration of the proteins
through ammonium sulfate precipitation, as in Fig. 1 A, in-
creases the level of interaction.
The yeast protein Vrp1p has been shown previously to
interact with both Bee1p and Myo5p (Anderson et al.,
1998; Naqvi et al., 1998). To determine whether the
Bee1p–type I myosin interaction was mediated by Vrp1p,
we performed immunoprecipitations of Myo3-HA from
Dvrp1 cells. Consistently, we find that Bee1p is still
present in the anti-HA immunoprecipitates, albeit at
lower levels than in wild-type cells, suggesting that at least
some fraction of the Bee1p interacts with type I myosins in
a Vrp1p-independent manner (Fig. 1 B). These results,
combined with the fact that both Bee1p and type I myo-
sins localize to cortical patches (Goodson et al., 1996; Li,
1997) suggest that these proteins interact in vivo.
Type I Myosins Are Required for the Reconstitution of 
Actin Assembly Sites
Type I myosins have traditionally been thought of as mo-
lecular motors that transport cargo along actin filaments
(Mooseker and Cheney, 1995). Therefore, their interac-
tion with a protein involved in regulating actin dynamics
was somewhat surprising. To determine whether the type I
Figure 2. Type I myosins are necessary for cortical actin poly-
merization. (A) Examples of positive (left panel, wild-type
extract), and negative (right panel, myo3G132R mutant extract)
results for the reconstitution of actin assembly sites in permeabi-
lized yeast cells. Assay conditions are described in Materials and
Methods. (B) Concentrated extracts were prepared from various
strains as indicated below the histograms and assayed for their
ability to restore actin assembly activity to urea-treated perme-
abilized yeast cells. Quantitation of cells that assembled
rhodamine actin into the bud was as described (Lechler and Li,
1997). For immunodepletion, anti-myc (mock depletion) or anti-
HA coupled protein A beads were added to concentrated ex-
tracts prepared from a strain that expresses Myo3-HA in the
Dmyo3  Dmyo5 background. After incubation, beads were pel-
leted and supernatants were removed for analysis. Gel inset
above corresponding lanes of the histogram, shows depletion of
Myo3-HA, but not Bee1p by the anti-HA beads. (C) Extracts
from wild-type and Dmyo3 Dmyo5 cells were mixed at the indi-
cated ratios and then assayed for their ability to restore actin as-
sembly in urea-treated permeabilized cells. The complementa-
tion efficiency was quantified and plotted against the extract
ratios. Each data point is an average of duplicate reactions.
Figure 1. Type I myosins associate with Bee1p. (A) High speed
extracts were prepared from a wild-type strain and a strain carry-
ing Bee1–protein A under the control of the BEE1 promoter.
Ammonium sulfate was added to 30% saturation, and precipi-
tated proteins were collected, resuspended, and bound to IgG–
Sepharose. After extensive washing, proteins were eluted with
0.5 M acetic acid, pH 3.6. Shown is part of a Coomassie blue–
stained gel that contains the indicated proteins: M, protein mo-
lecular weight markers; C, control (untagged wild-type extract);
B, Bee1–protein A extract. The identity of proteins determined
by mass spectroscopy analysis is indicated. (B) Extracts were pre-
pared from strains carrying Myo3-HA under the control of the
MYO3 promoter in either wild-type or Dvrp1 backgrounds. Im-
munoprecipitation was performed with anti-HA or anti-myc
(control immunoprecipitate) coupled protein A beads. After
washing and elution, proteins were subjected to SDS-PAGE,
transferred to nitrocellulose, and blotted with the anti-Bee1p an-
tibody (Winter et al., 1999a). The extract lane is loaded with 5%
of the input extract.Lechler et al. Myosin I Regulates Actin Polymerization 367
myosins have a direct role in the production of actin fil-
aments, extracts were prepared from single or double my-
osin knockout yeast strains and tested for their ability to
reconstitute actin assembly in urea-inactivated permeabi-
lized cells. Typical positive and negative results of this as-
say are shown in Fig. 2 A. Extracts prepared from Dmyo3
cells or Dmyo5 cells were able to restore actin assembly ac-
tivity to the urea-inactivated permeabilized yeast cells to
the same extent as wild-type extracts (Fig. 2 B). However,
extracts from Dmyo3  Dmyo5 double mutant showed no
more activity than addition of buffer alone. Therefore, the
type I myosins are required for the actin assembly activity
and appear to be functionally redundant in this assay as
they are in vivo.
To demonstrate that the type I myosins are required for
actin polymerization in a dose-dependent manner, wild-
type and Dmyo3 Dmyo5 extracts were mixed at varying ra-
tios to vary the concentration of the type I myosin at the
same time as maintaining the concentration of other active
components (Fig. 2 C). We find that as type I myosin con-
centration decreases, the ability to assemble actin also de-
creases. This closely resembles the results seen by dilution
of wild-type extract with buffer alone (Lechler and Li,
1997), suggesting that the type I myosins are limiting fac-
tors in the wild-type extract.
To ensure that the lack of activity in the Dmyo3 Dmyo5
extract was not due to unhealthiness of the double mutant
cells, we tested whether biochemical depletion of the type
I myosins also led to a loss of ability to reconstitute actin
assembly. To do so, a strain was generated that contained
the HA-tagged Myo3p in the Dmyo3 Dmyo5 background.
Therefore, Myo3-HA was the only source of type I myo-
sins in this strain. The Myo3-HA rescued the growth de-
fect of the double deletion strain (data not shown). Ex-
tracts were prepared from this strain and then mixed with
protein A–Sepharose beads conjugated to either anti-HA
or anti-myc (control) antibodies. Immunodepletion of the
Myo3-HA is demonstrated in the immunoblot as shown in
Fig. 2 B. Bee1p as well as the actin nucleator Arp2/3 com-
plex (data not shown) were not significantly depleted from
extracts by this treatment. The Myo3-depleted extract
lacked the ability to restore actin assembly in urea-inacti-
vated cells, whereas mock depletion had little effect (Fig. 2
B). These results support a direct involvement of the type
I myosins in cortical actin assembly.
Motor Activity of Type I Myosins Is Necessary for 
Cortical Actin Polymerization
Type I myosins consist of an NH2-terminal motor domain
harboring the ATP and actin binding sites, followed by a
tail domain that is thought to interact with cargos and
other cytoskeletal proteins. We first took a pharmacologi-
cal approach to determine whether the motor activity of
myosins is required for actin polymerization. BDM is a
low affinity inhibitor of myosins (Backx et al., 1994;
Cramer and Mitchison, 1995). To separate the effect of the
drug on the reconstitution of actin assembly sites from that
on actin polymerization, BDM was either added during
the incubation with the extract but washed out before the
polymerization step, or was only present during the poly-
merization step. Addition of 20 mM BDM to extracts dur-
ing reconstitution had no effect on actin assembly (data
not shown), but when BDM was added with G-actin at the
time of polymerization, actin assembly into the permeabi-
lized cells was inhibited (Fig. 3). Similarly, addition of
AMPPNP to extracts during the reconstitution had no ef-
fect on actin assembly activity (data not shown); however,
when added with G-actin at the time of polymerization, it
inhibited actin polymerization (Fig. 3). Because neither
the same concentration of BDM nor AMPPNP blocked
spontaneous assembly of pyrene-labeled actin (data not
shown), these results suggest that myosin motor domain
activity is not required during the reconstitution (e.g., to
localize the proteins), but is required for actin polymeriza-
tion at the cell cortex.
These pharmacological experiments support a role for
myosins and ATP hydrolysis in actin assembly. However,
care must be taken in interpreting these results, as the
specificities of these inhibitors are broad. To further test
the requirement of myosin motor activity in actin poly-
merization, Glycine132, within the P-loop required for nu-
cleotide binding of Myo3p, was mutated to an arginine res-
idue. Similar mutations in this loop of other myosins lead
to an inability to bind nucleotide (Bejsovec and Anderson,
1990). Since nucleotide-free myosin binds tightly to actin
filaments, these mutations are known as rigor mutations.
The myo3G132R mutation results in a complete loss of
function: it did not rescue the growth defect of the Dmyo3
Dmyo5 strain (data not shown). Extracts prepared from a
strain carrying the rigor Myo3p as its sole source of type I
myosins (i.e., in the Dmyo3 Dmyo5 background) were un-
able to restore actin assembly activity to the permeabilized
cells (Fig. 3). This result further suggests that type I myo-
sins require a functional motor domain in order to pro-
mote actin polymerization.
Type I Myosins Mediate Cdc42p Regulation of Cortical 
Actin Assembly
The distribution of actin patches in vivo as well as actin
Figure 3. Myosin motor activity is required for actin assembly.
Reconstitution was performed with buffer or extracts as listed in
the first line under the histogram. Polymerization was performed
in the presence of 1 mM ATP (2), 1 mM ATP plus 20 mM BDM,
or with 1 mM AMPPNP (with no ATP), as indicated below the
histogram. Reconstitution procedure and quantitation of the re-
sults were performed as described (Lechler and Li, 1997).The Journal of Cell Biology, Volume 148, 2000 368
polymerization in the permeabilized cells are dependent
on the small GTPase Cdc42 (Adams et al., 1990; Li et al.,
1995), but the mechanism by which Cdc42 regulates actin
assembly in yeast was not understood. Because the motor
activity of type I myosins, which appears to be required for
cortical actin polymerization, is stimulated through phos-
phorylation by PAKs (Maruta and Korn, 1977; Wu et al.,
1996; Brzeska et al., 1997, 1999), it is possible that the type
I myosins mediate Cdc42 regulation of actin assembly
through motor domain phosphorylation. Mutation of the
conserved serine residue (ser357) to alanine in Myo3 leads
to a complete loss of function, whereas mutation to as-
partate has no phenotype (Wu et al., 1997). To test the ef-
fects of these mutations on actin assembly, extracts were
prepared from strains carrying the myo3S357A and
MYO3S357D mutants as their sole source of type I my-
osins. The myo3S357A mutant extract was unable to re-
store actin assembly in urea-treated cells, whereas the
MYO3S357D mutant extract reproducibly showed slightly
higher levels of activity than wild-type extracts (Fig. 4 A).
To further establish a requirement of myosin I phosphor-
ylation in cortical actin assembly, we reasoned that if this
were true then the extract used for reconstitution of actin
assembly should be sensitive to phosphatase treatment. In
fact, incubation of extracts with alkaline phosphatase
caused almost a complete loss of actin assembly activity
(Fig. 4 A). Treatment of the MYO3S357D extract with
phosphatase, on the other hand, had very little effect on
the activity of the extract. These data confirm the require-
ment for myosin I phosphorylation in actin assembly, and
suggest that it is the only phosphorylation required for the
reconstitution of actin assembly sites.
We showed previously that the actin assembly activity in
permeabilized yeast cells was abolished by the cdc42-1
mutation (Li et al., 1995). If phosphorylation of the type I
myosins is a key downstream event in the activation of ac-
tin assembly, then the MYO3S357D mutation may rescue
the actin assembly defect of cdc42-1 cells. To test this pos-
sibility, the MYO3S357D and myo3S357A alleles were
transformed into cdc42-1 cells, and actin polymerization
was assayed in the permeabilized cells from the resulting
strains. As shown in Fig. 4 B, permeabilized cdc42-1 cells
expressing  MYO3S357D regained actin polymerization
activity, whereas those expressing the myo3S357A allele
were as defective as the untransformed cdc42-1 cells. This
result supports the hypothesis that type I myosins are a
key target of active Cdc42p in promoting actin polymer-
ization.
Involvement of Type I Myosins in the Activation of the 
Arp2/3 Complex
A unique feature of the yeast type I myosins that is not
shared by known type I myosins of other organisms is the
presence of an acidic region at the COOH-terminus. This
domain shows significant similarity to the acidic COOH-
terminal tails of Bee1p and other members of WASP fam-
ily proteins. Over z35 aa, the Myo3p and Myo5p tails are
45% conserved with the Bee1p tail motif (Fig. 5 A). This
motif mediates the interaction of WASP family proteins
with the Arp2/3 complex and is essential for activation of
the Arp2/3 complex’s nucleation activity in vitro (Ma-
chesky and Insall, 1998; Winter et al., 1999a). To deter-
mine if the myosins could interact with the Arp2/3 com-
plex through the acidic motif, beads coupled to GST
fusions of Myo3p or Myo5p COOH-terminal acidic frag-
ments (GST-Myo3A and GST-Myo5A) were incubated
with purified Arp2/3 complex, washed, and then examined
for the presence of Arp2p. Arp2p was found associated
with these fusion proteins to the same extent as with the
Bee1p acidic domain (GST-Bee1A) (Fig. 5 B). To deter-
mine whether the interaction between the type I myosins
and Arp2/3 complex occurs in vivo, we immunoprecipi-
tated HA-tagged Myo3p expressed at an endogenous level
from cell extracts, and blotted with an antibody against
Arp2p. Arp2p was detected in Myo3-HA immunoprecipi-
tates but not in control immunoprecipitates (Fig. 5 C). As
we have found previously with Bee1p, this interaction is of
Figure 4. Phosphorylation of
type I myosins is an impor-
tant step in the stimulation
of actin polymerization by
Cdc42p. (A) Reconstitution
of actin assembly sites was
carried out with concentrated
extracts prepared from strains
carrying the myo3S357A and
MYO3S357D mutants as
their only source of type I
myosins. Reconstitution pro-
cedure and quantitation of
the results were performed as
described (Lechler and Li,
1997). AP: alkaline phos-
phatase used for treating
wild-type or MYO3S357D
mutant extracts (see text).
(B) A mutant Myo3p mimicking constitutive phosphorylation rescues the actin assembly defect of a temperature-sensitive CDC42 al-
lele. Wild-type, cdc42-1, and cdc42-1 cells expressing MYO3S357D or myo3S357A under the endogenous MYO3 promoter were grown
at room temperature, shifted to 348C for 2 h, permeabilized, and subjected to rhodamine actin assembly assays as described (Li et al.,
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low affinity, and ,1% of total Arp2p is immunoprecipi-
tated with the type I myosins (data not shown). The
COOH-terminal domain of Myo3p was required for this
interaction, as a deletion mutant lacking the COOH-ter-
minal 34 aa no longer immunoprecipitated Arp2p (Fig. 5
C). This result, together with the observation that Myo3p,
Myo5p, Arp2p, and Arp3p all localize to cortical actin
patches, suggest that the type I myosins and the Arp2/3
complex interact in vivo (Goodson et al., 1996; Moreau
et al., 1996; Winter et al., 1997).
We showed previously that deletion of the Arp2/3-inter-
acting domain of Bee1p does not cause severe defects in
cortical actin organization, as opposed to disruption of the
entire  BEE1 gene or subunits of the Arp2/3 complex
(Winter et al., 1999a). To determine whether this lack of
phenotype was due to redundant functions of the homolo-
gous domains in the type I myosins, strains were created
that contained deletions of these domains in combination.
The growth defect of a Dmyo3 Dmyo5 double mutant is
fully rescued by an allele of Myo5p in which the COOH-
terminal Arp2/3-interacting domain (34 aa) was deleted
(myo5DA) (Fig. 6 A). However, although neither the
bee1DA mutation alone nor the myo5DA truncation in the
Dmyo3 Dmyo5 double mutant background showed any se-
vere phenotypes, a combination of the two in the Dmyo3
Dmyo5 double mutant background had a clear synthetic
effect: the mutant cells grew almost as poorly as BEE1-
null cells at 308C and did not grow at 378C. The double
mutant cells also show severe defects in actin organization
and accumulate abnormal F-actin aggregates, characteris-
tic of null alleles of BEE1 and genes encoding subunits of
the Arp2/3 complex (Fig. 6 B) (Li, 1997; Winter et al.,
1999b). These data suggest that the homologous COOH-
terminal domains of Bee1p and type I myosins have a re-
dundant but important role in regulation of the actin in
vivo.
This synthetic effect is also evident in vitro. Extracts
were prepared from the bee1DA, the myo5DA Dmyo3, and
the bee1DA myo5DA Dmyo3 strains and tested for their
ability to reconstitute actin polymerization in the urea-
inactivated permeabilized cells. Whereas the actin assem-
bly activity was intact in the former two extracts, an ex-
tract from the strain lacking both Bee1p and Myo5p
COOH-terminal acidic domains (in the Dmyo3  Dmyo5
double mutant background) had essentially no activity
(Fig. 7 A). These results suggest that the COOH-terminal
domains of Bee1p and Myo5p share a redundant function
both in vivo and in vitro. Finally, to address how the con-
centration of these activation domains affects actin assem-
bly activity, we titrated wild-type extract with the bee1DA
myo5DA  Dmyo3 extract (Fig. 7 B). Actin assembly de-
creases at low levels of the activation domain; however,
actin assembly is less sensitive to loss of activation do-
mains than to loss of type I myosins (compare Fig. 2 C and
Fig. 7 B).
Discussion
Type I myosins are a highly conserved family of molecular
motors, first identified almost 30 years ago (for review see
Mooseker and Cheney, 1995). In spite of this, precise in
vivo function of these myosins have not been defined. Ge-
netic and biochemical evidence in Acanthamoeba, Dic-
tyostelium, and yeast have implicated these proteins in
actin-based processes such as cell motility, phagocytosis,
endocytosis, and contractile activity (Mooseker and Che-
ney, 1995). Type I myosins have been hypothesized to
transport membranous vesicles or to provide contractile
force on actin filaments in order to function in these pro-
cesses. Here we have presented evidence that type I myo-
sins are directly involved in the promotion of actin assem-
bly at the cell cortex.
Myo3p and Myo5p physically interact with Bee1p, the
yeast WASP homologue. This interaction appears to be of
Figure 5. Type I myosins in-
teract with the Arp2/3 com-
plex. (A) Alignment of the
COOH-terminal acidic do-
mains of Myo3p, Myo5p, and
Bee1p. Residues conserved in
all three are in bold. (B) GST
fusions to the COOH-termi-
nal 38 aa of Myo3p and the
COOH-terminal 54 aa of
Myo5p and Bee1p were puri-
fied from bacteria. Fusion
proteins bound to glu-
tathione-agarose beads were
incubated with 50 nM Arp2/3
complex purified as described
(Winter et al., 1999b). After
washing, bound proteins were
eluted into SDS-PAGE sam-
ple buffer. Upper panel, anti-
Arp2p immunoblot; lower
panel, Coomassie-stained gel
showing that equal amounts of GST fusion proteins were added. (C) Extracts at 15 mg/ml were prepared from strains carrying Myo3-
HA or Myo3DA-HA (Myo3p lacking the COOH-terminal acidic domain) in the Dmyo3 Dmyo5 background. Anti-myc (control immuno-
precipitate) and anti-HA immunoprecipitations were performed, and bound proteins were analyzed by immunoblotting with anti-Arp2p
antibodies. Extracts used are listed below the gel. The extract lane shows the presence of Arp2p in preimmunoprecipitate extracts.The Journal of Cell Biology, Volume 148, 2000 370
low affinity, as only a small fraction coimmunoprecipi-
tates. However, we consistently find that increasing ex-
tract concentration increases the amount of bound pro-
teins. In the case where extracts were first precipitated
with 30% ammonium sulfate, we achieved a 28-fold con-
centration over the starting extract, leading to an almost
stoichiometric interaction between the proteins. This sug-
gests that with the high in vivo concentrations of these
proteins in cortical patches, the majority of these proteins
may be in complex. The interaction between Bee1p and
the myosins is likely to occur through interaction of the
SH3 domain of the myosins and the proline-rich repeats of
Bee1p (M. Evangelista and C. Boone, personal communi-
cation). The only other identified ligand for the SH3 do-
main of type I myosins is Acan125, a protein purified from
Acanthamoeba which shows no homology to Bee1p (Xu et
Figure 7. Bee1p and type I
myosin acidic tails function
redundantly in actin assem-
bly. (A) Concentrated ex-
tracts were prepared from
the strains as indicated and
tested for their ability to re-
store the actin assembly ac-
tivity of urea-treated per-
meabilized yeast cells.
Reconstitution procedure
and quantitation of the re-
sults were performed as de-
scribed (Lechler and Li,
1997). (B) Extracts from
wild-type and bee1DA
myo5DA  Dmyo3 cells were
mixed at the indicated ratios on the horizontal axis and then assayed for their ability to restore actin assembly in urea-treated permeabi-
lized cells. The complementation efficiency was quantified and plotted against the extract ratios. Each data point is an average of dupli-
cate reactions.
Figure 6. The type I myosin
and Bee1p acidic tails have
redundant functions. (A)
Equal concentration of cells
from strains as indicated were
spotted onto yeast extract,
peptone, dextrose (YPD)
plates, grown for 36 h, and
then photographed. myo5DA
Dmyo3: a strain expressing
myo5DA in the Dmyo3
Dmyo5 double mutant back-
ground;  bee1DA myo5DA
Dmyo3: a strain expressing
bee1DA and myo5DA in the
Dmyo3 Dmyo5 double mutant
background. (B) Rhodamine-
phalloidin staining (upper
panels) and differential inter-
ference contrast (DIC) im-
ages (lower panels) of wild-
type and bee1DA myo5DA
Dmyo3 cells grown at room
temperature.Lechler et al. Myosin I Regulates Actin Polymerization 371
al., 1997). Interestingly, the Bee1p binding protein, Vrp1p,
also interacts with the SH3 domain of type I myosins
(Anderson et al., 1998; Naqvi et al., 1998). Since the SH3
domain of the yeast type I myosins was shown to be im-
portant for their localization to actin patches (Anderson et
al., 1998), it is possible that Bee1p and Vrp1p function re-
dundantly in targeting the myosins to regions of actin as-
sembly. Another possibility is that Bee1p and Vrp1p are
cargo for the myosins and are transported to the barbed
ends of filaments by these molecular motors (see below).
Regardless, since all these proteins have mammalian coun-
terparts (Vrp1p is a homologue of the mammalian WASP-
interacting protein [WIP] protein [Ramesh et al., 1997]), it
would be interesting to test if their complex formation is
also conserved.
The type I myosins also interact with the Arp2/3 com-
plex. The COOH-terminal tails of Myo3p and Myo5p
show significant homology to the COOH-terminal tails of
Bee1p and other WASP family proteins. These acidic tails
are actually more similar to WASP and N-WASP than
they are to Bee1p, as they have a large net negative
charge, as opposed to Bee1p which has a more neutral
charge. These motifs mediate a direct physical interaction
with the Arp2/3 complex. This interaction is likely to occur
in vivo, as Arp2/3 complex can be immunoprecipitated
with the type I myosins, an association that is dependent
upon the COOH-terminal tail of the myosins. There are
several possible functions for this interaction. First, it
could be involved in localization of either the myosins or
the Arp2/3 complex. This is unlikely, as Arp2/3 complex
localization is not affected by deletion of the myosin acidic
tail motif (data not shown). Also, deletion of the myosin
acidic tails causes no obvious defects in the presence of
wild-type Bee1p, suggesting that myosin localization is un-
likely to be abolished. Another possible function for the
myosin–Arp2/3 interaction could be to activate the nucle-
ation activity of the Arp2/3 complex. This possibility is
supported by three findings. First, homologous motifs in
Bee1p and WASP proteins have been shown to be re-
quired for the activation of the Arp2/3 complex (Ma-
chesky et al., 1999; Rohatgi et al., 1999; Winter et al.,
1999a; Yarar et al., 1999). Second, we found a specific syn-
thetic interaction due to loss of the Bee1p and myosin I
acidic motifs: loss of the Arp2/3-activating acidic domain
of either Bee1p or the type I myosins does not cause a dra-
matic phenotype; however, in combination, these dele-
tions lead to drastic growth and actin organization defects.
Third, by using an in vitro reconstitution assay, we showed
that loss of the acidic motifs of Bee1p and type I myosins
causes a defect in actin assembly activity. These data sup-
port redundant functions of the myosin and Bee1p acidic
domains in activation of the Arp2/3 complex.
It was surprising to us that an involvement in actin poly-
merization is not limited to the tail domain of type I myo-
sin, but that motor activity is also required. The require-
ment for myosin motor activity in actin polymerization
may be explained by one of the following models. First,
the type I myosins may function by transporting nucle-
ation or elongation machinery to the barbed ends of exist-
ing filaments. If the cargo is a WASP family member or
the Arp2/3 complex, this would ensure that the nucleation
machinery remains near the barbed end of filaments, pro-
moting the generation of dendritic actin filaments at the
membrane cortex. Alternatively, if the cargo is an elonga-
tion machinery (Zigmond et al., 1998), it could serve to
maintain this machinery at the growing barbed end of ac-
tin filaments. Type I myosins may also function in cortical
filament assembly as a molecular ratchet. In this model,
type I myosins associate with the membrane through the
lipid-binding domain within their tails (Adams and Pol-
lard, 1989); movement of the myosin head along actin to-
wards the barbed end could then generate a membrane
protrusion, allowing addition of G-actin onto the barbed
end. This would explain the requirement for myosin motor
activity during polymerization. In filopodia, it has been
proposed that such a function may be important for cou-
pling polymerization and leading edge protrusion (Sheetz
et al., 1992). One caveat is that all of these models imply
processivity of the myosin motor. In vitro experiments
suggested that individual myosin I molecules are unlikely
to remain bound to F-actin long enough to translocate
through any significant distance (Ostap and Pollard, 1996).
However, other experiments have shown that myosin I can
transport vesicles or F-actin filaments (Adams and
Pollard, 1986; Zot et al., 1992), possibly due to a second
F-actin binding site in the myosin I tail that can cross-link
actin filaments (Fujisaki et al., 1985). An alternative possi-
bility is that the type I myosins do not function like con-
ventional motors in promoting actin assembly. For exam-
ple, members of the Kin I kinesin family of microtubule
motors have been shown to use their microtubule-depen-
dent ATPase activity to catalyze the depolymerization of
microtubules (Desai et al., 1999).
The mammalian N-WASP protein has been shown to
mediate Cdc42-dependent actin polymerization by inter-
acting directly with Cdc42 (Miki et al., 1998a; Rohatgi et al.,
1999). However, WASP-family proteins such as Bee1p
and WAVE, do not contain the Cdc42-binding motif (Li,
1997; Miki et al., 1998b). In yeast, PAKs are known Cdc42
effectors. The involvement of yeast PAKs in actin poly-
merization was first suggested by the result that overex-
pression of Ste20p, a yeast PAK, suppresses both the po-
larization and actin assembly defects of cdc42-1 mutant
(Eby et al., 1998). We have shown here that a mutation in
Myo3p mimicking constitutive phosphorylation of the site
known to be acted upon by PAKs rescues the actin assem-
bly defects in cdc42-1 mutant cells. This finding suggests
that Myo3p and probably also Myo5p are major targets of
Cdc42p/PAK in the regulation of actin assembly at the
cell cortex. A function in mediating polarized actin as-
sembly may explain the phenotype of myosin I mutant
Dictyostelium cells that exhibit defects in maintaining di-
rection of movement in chemotactic streaming assays
(Jung et al., 1996; Titus et al., 1993). Since the PAK
phosphorylation site is conserved in amoeba type I myo-
sins, but not in those of higher cells, it is possible that
this pathway of actin regulation by small GTPases only
operates in protozoan organisms. However, the mamma-
lian type VI myosins, which were recently shown to
move toward the pointed ends of actin filaments (Wells
et al., 1999), have the same PAK phosphorylation sites
(Buss et al., 1998). It will be interesting to define the role
of these myosins in actin polymerization and actin-based
motility.The Journal of Cell Biology, Volume 148, 2000 372
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